Sai Life Sciences Opens Dedicated Facility for Veterinary APIs in Bidar, India
Sep 19, 2025
Hyderabad (Telangana) [India], September 19: Sai Life Sciences (BSE: 544306 | NSE: SAILIFE), an innovator-focused Contract Research, Development, and Manufacturing Organization (CRDMO), today announced the opening of Unit VI, a dedicated facility for Veterinary Active Pharmaceutical Ingredient (API) production, in Bidar, India. Located alongside Unit IV, the company's flagship API manufacturing site, Unit VI has been established exclusively for veterinary APIs.